– Topline data from confirmatory Launch-HTN trial expected in 2H 2025 – – Topline data from ongoing Advance-HTN pivotal trial […]
SEATTLE, Dec. 21, 2023 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading marketing technology […]
HOUSTON, Dec. 21, 2023 (GLOBE NEWSWIRE) — Great Lakes Dredge & Dock Corporation (“Great Lakes” or the “Company”) (NASDAQ: GLDD), […]
NEW YORK, Dec. 21, 2023 (GLOBE NEWSWIRE) — Hudson Acquisition I Corp. (the “Company” or “Hudson”) (Nasdaq: HUDA), announced today […]
Highlights: Incannex subsidiary, Clarion Clinics, has received Human Research Ethics Committee (HREC) endorsement for administration of psychedelic-assisted therapies for TRD […]
OXNARD, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) — Mission Produce, Inc. (Nasdaq: AVO) (“Mission” or the “Company”), a world leader […]
BOSTON, Dec. 21, 2023 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology company focused on the development […]
REDWOOD CITY, Calif., Dec. 21, 2023 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a […]
ATHENS, Greece, Dec. 21, 2023 (GLOBE NEWSWIRE) — Capital Product Partners L.P. (the “Partnership”, “CPLP”, or “we”/ “us”) (NASDAQ:CPLP) today […]
Second quarter sales of $545 million, up 16% over the prior year Second quarter GAAP diluted earnings per share from […]
